These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37067735)

  • 1. Genomic Profiling of Lower-Grade Gliomas Subtype with Distinct Molecular and Clinicopathologic Characteristics via Altered DNA-Damage Repair Features.
    Maimaiti A; Liu Y; Abulaiti A; Wang X; Feng Z; Wang J; Mijiti M; Turhon M; Alimu N; Wang Y; Liang W; Jiang L; Pei Y
    J Mol Neurosci; 2023 May; 73(4-5):269-286. PubMed ID: 37067735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of DNA Damage Repair Related Signature and Molecular Feature in Low-Grade Gliomas to Aid Chemotherapy and Drug Discovery.
    Yin X; Li M; He Z
    Front Biosci (Landmark Ed); 2023 Oct; 28(10):234. PubMed ID: 37919061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive regulators of T cell functions as predictors of prognosis and microenvironment characteristics of low-grade gliomas.
    Li Y; Feng Y; Luo F; Peng G; Li Y
    Front Immunol; 2022; 13():1089792. PubMed ID: 36726969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA Damage Repair Profiles Alteration Characterize a Hepatocellular Carcinoma Subtype With Unique Molecular and Clinicopathologic Features.
    Lin P; Gao RZ; Wen R; He Y; Yang H
    Front Immunol; 2021; 12():715460. PubMed ID: 34456923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An integrative multi-omics analysis based on liquid-liquid phase separation delineates distinct subtypes of lower-grade glioma and identifies a prognostic signature.
    Zheng J; Wu Z; Qiu Y; Wang X; Jiang X
    J Transl Med; 2022 Jan; 20(1):55. PubMed ID: 35093128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a novel cuproptosis-related gene signature and integrative analyses in patients with lower-grade gliomas.
    Bao JH; Lu WC; Duan H; Ye YQ; Li JB; Liao WT; Li YC; Sun YP
    Front Immunol; 2022; 13():933973. PubMed ID: 36045691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The DNA methylome of DDR genes and benefit from RT or TMZ in IDH mutant low-grade glioma treated in EORTC 22033.
    Bady P; Kurscheid S; Delorenzi M; Gorlia T; van den Bent MJ; Hoang-Xuan K; Vauléon É; Gijtenbeek A; Enting R; Thiessen B; Chinot O; Dhermain F; Brandes AA; Reijneveld JC; Marosi C; Taphoorn MJB; Wick W; von Deimling A; French P; Stupp R; Baumert BG; Hegi ME
    Acta Neuropathol; 2018 Apr; 135(4):601-615. PubMed ID: 29368212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA methylation, transcriptome and genetic copy number signatures of diffuse cerebral WHO grade II/III gliomas resolve cancer heterogeneity and development.
    Binder H; Willscher E; Loeffler-Wirth H; Hopp L; Jones DTW; Pfister SM; Kreuz M; Gramatzki D; Fortenbacher E; Hentschel B; Tatagiba M; Herrlinger U; Vatter H; Matschke J; Westphal M; Krex D; Schackert G; Tonn JC; Schlegel U; Steiger HJ; Wick W; Weber RG; Weller M; Loeffler M
    Acta Neuropathol Commun; 2019 Apr; 7(1):59. PubMed ID: 31023364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrence- and Malignant Progression-Associated Biomarkers in Low-Grade Gliomas and Their Roles in Immunotherapy.
    Teng C; Zhu Y; Li Y; Dai L; Pan Z; Wanggou S; Li X
    Front Immunol; 2022; 13():899710. PubMed ID: 35677036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrative analyses identify a DNA damage repair gene signature for prognosis prediction in lower grade gliomas.
    Pang FM; Yan H; Mo JL; Li D; Chen Y; Zhang L; Liu ZQ; Zhou HH; Wu J; Li X
    Future Oncol; 2020 Mar; 16(8):367-382. PubMed ID: 32065545
    [No Abstract]   [Full Text] [Related]  

  • 11. DNA damage repair alterations modulate M2 polarization of microglia to remodel the tumor microenvironment via the p53-mediated MDK expression in glioma.
    Meng X; Duan C; Pang H; Chen Q; Han B; Zha C; Dinislam M; Wu P; Li Z; Zhao S; Wang R; Lin L; Jiang C; Cai J
    EBioMedicine; 2019 Mar; 41():185-199. PubMed ID: 30773478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrinsic immune evasion patterns predict temozolomide sensitivity and immunotherapy response in lower-grade gliomas.
    Tu Z; Ji Q; Han Q; Long X; Li J; Wu L; Huang K; Zhu X
    BMC Cancer; 2022 Sep; 22(1):973. PubMed ID: 36096781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia-Related lncRNA Correlates With Prognosis and Immune Microenvironment in Lower-Grade Glioma.
    Xu S; Tang L; Liu Z; Luo C; Cheng Q
    Front Immunol; 2021; 12():731048. PubMed ID: 34659218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RFC2: a prognosis biomarker correlated with the immune signature in diffuse lower-grade gliomas.
    Zhao X; Wang Y; Li J; Qu F; Fu X; Liu S; Wang X; Xie Y; Zhang X
    Sci Rep; 2022 Feb; 12(1):3122. PubMed ID: 35210438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PLEKHA4 is a novel prognostic biomarker that reshapes the tumor microenvironment in lower-grade glioma.
    Zhi W; Wang Y; Jiang C; Gong Y; Chen Q; Mao X; Deng W; Zhao S
    Front Immunol; 2023; 14():1128244. PubMed ID: 37818357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma.
    Lu J; Peng Y; Huang R; Feng Z; Fan Y; Wang H; Zeng Z; Ji Y; Wang Y; Wang Z
    BMC Cancer; 2021 Jun; 21(1):723. PubMed ID: 34162355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic transcriptome profiling of pyroptosis related signature for predicting prognosis and immune landscape in lower grade glioma.
    Yu H; Gong M; Qi J; Zhao C; Niu W; Sun S; Li S; Hong B; Qian J; Wang H; Chen X; Fang Z
    BMC Cancer; 2022 Aug; 22(1):885. PubMed ID: 35964070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrative multi-omics analysis unveils the connection between transcriptomic characteristics associated with mitochondria and the tumor immune microenvironment in lower-grade gliomas.
    Jiang C; Wu W; Jiang X; Qian K
    Sci Rep; 2024 Oct; 14(1):23675. PubMed ID: 39390013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of three heterogeneous subtypes and a risk model of low-grade gliomas based on cell senescence-related genes.
    Chen J; Wu L; Yang H; Zhang X; Xv S; Qian Q
    Front Immunol; 2022; 13():982033. PubMed ID: 36052073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas.
    Zhang H; Li X; Li Y; Chen B; Zong Z; Shen L
    Front Immunol; 2020; 11():603341. PubMed ID: 33363544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.